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Editorial
Percutaneous Renal  
Sympathetic Denervation 
Áurea J. Chaves
Drug-resistant arterial hypertension is defined as the high blood bressure pressure that remains uncontrolled, despite treatment with at least 
three drugs at the maximum tolerated doses. These pa-
tients have a 50% higher chance of developing adverse 
events when compared to those with controlled blood 
pressure. Increased activity of the sympathetic nervous 
system and the renin-angiotensin-aldosterone II system 
is the physiopathological basis of this condition; the 
connection between these two systems is formed by the 
network of sympathetic fibres located in the adventitia 
of renal arteries. These nerves can be targeted by the 
application of radiofrequency (RF) energy, released by 
catheters positioned in the lumen of renal arteries, an 
approach that has attracted considerable interest over 
the past two years.
In this issue of Revista Brasileira de Cardiologia 
Invasiva (Brazilian Journal of Invasive Cardiology – 
RBCI), we present two articles, with their respective 
edito rials, addressing the initial experience in Brazil with 
percutaneous renal sympathetic denervation. Staico et 
al., from the Instituto Dante Pazzanese de Cardiologia 
(São Paulo, SP), present their unpublished work, in 
which they compare the effects, on different tissues, 
of different types of catheters, as well as powers and 
times of application of RF in an experimental model 
with renal arteries ex vivo. One of the three catheters 
used was an electrode irrigated with saline solution, 
which demonstrated improved safety and efficacy in 
intracardiac ablation when compared to non-irrigated 
catheters. In his editorial, Healey, from McMaster Uni-
versity (Hamilton, Canada), congratulates the authors for 
their cautious approach in conducting the experiment, 
but reminds that the use of these catheters is an off-label 
indication for renal sympathetic denervation, and such 
techniques, different from those already tested, should 
be subjected to the same assessment performed with 
dedicated catheters.
Armaganijan et al., from the Instituto Dante Pazza-
nese de Cardiologia (São Paulo, SP), assess the quality 
of life of the first patients undergoing renal sympathetic 
denervation for resistant hypertension. They administered 
the EuroQol-5 Dimensions (EQ-5D-5L) questionnaire 
before and three months after the procedure. This 
questionnaire, which assesses health status, consists of 
a descriptive system that defines quality of life in five 
dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression), with five different 
levels of severity and a visual scale ranging from 0 
to 100, in which patients indicate perception of their 
health status. It is interesting to observe the low health 
scores of patients with resistant hypertension and which 
findings are associated with improved health status 
after the procedure.
Quadros, from the Instituto de Cardiologia/Fundação 
Universitária de Cardiologia (Porto Alegre, RS), one of the 
pioneers in the study of quality of life in Brazil, recalls 
the importance of addressing this issue, in addition to 
the concern about prolonged survival, regarding treat-
ments given to patients. He congratulates the authors 
for the initiative, but states that other studies should 
be performed to clarify pending issues, such as the 
reproducibility of the positive results of the Symplicity 
Trial, with the use of cardiac ablation catheters.
Two other studies evaluate contemporary therapies 
in the interventionist area. Pinton et al., from Instituto 
do Coração do Hospital das Clínicas da Faculdade de 
Medicina da Universidade de São Paulo. São Paulo, 
SP, Brazil, assess patients admitted with acute coronary 
syndrome who had femoral artery pseudoaneurysm after 
percutaneous procedure, treated with ultrasound-guided 
thrombin injection. They demonstrate the high success 
rate of the technique, regardless of the pseudoaneurysm 
complexity and the use of dual antiplatelet therapy. It 
is an attractive option in experienced hands, compared 
to ultrasound-guided pseudoaneurysm compression or 
surgery. 
Guimarães et al., from the Instituto Dante Pazza nese 
de Cardiologia (São Paulo, SP), present the evolution of 
patients with de novo coronary lesions in native vessel 
or bypass surgery, and angiographic characteristics such 
as thrombus, ulceration, and filling defect; and/or in 
the presence of acute coronary syndrome, treated with 
the MGuardTM stent. This is a stent whose metal struts 
are covered with a dual polymer network, designed 
specifically for the prevention of distal embolization 
during percutaneous coronary intervention (PCI). The 
importance of this study lies in the extensive angio-
graphic characterization and the procedure technique, 
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which allows for the operational evaluation of the 
device performance. The in-hospital and late clinical 
outcomes should be interpreted in the context of the 
small series of treated patients. 
Finally, we invite readers to explore in depth the 
other articles in this issue, with topics that range from 
antithrombotic drug-therapy post-primary PCI from 
the national ACCEPT registry, to transradial PCI in 
the elderly, PCI in insulin-using diabetics, radiological 
exposure in patients with complex lesions submitted 
to PCI, radiological exposure in patients undergoing 
procedures by radial approach, use of ultrasound 
asso ciated to virtual histology to evaluate the necrotic 
core of coronary lesions in areas with positive vascular 
remodeling, and the percutaneous occlusion of patent 
ductus arteriosus in adults.
Enjoy your reading!
Áurea J. Chaves 
Editor
